Smith Thomas J, Hillner Bruce E, Kelly Ronan J
From the Palliative Medicine Program, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, MD; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA.
Am Soc Clin Oncol Educ Book. 2012:e46-51. doi: 10.14694/EdBook_AM.2012.32.183.
Health care and cancer care costs are rising unsustainably such that insurance costs have doubled in 10 years. Oncologists find themselves both victims of high costs and the cause of high-cost care by what we do and what we do not do. We previously outlined five ways that oncologists could personally bend the cost curve downward and five societal attitudes that would require change to lower costs. Here, we present some practical ways to reduce costs while maintaining or improving quality, including: 1) evidence-based surveillance after curative therapy; 2) reduced use of white cell stimulating factors (filgrastim and pegfilgrastim); 3) better integration of palliative care into usual oncology care; and 4) use of evidence-based, cost-conscious clinical pathways that allow appropriate care and lead to equal or better outcomes at one-third lower cost.